Form 8-K - Current report:
SEC Accession No. 0001213900-25-050327
Filing Date
2025-06-03
Accepted
2025-06-03 07:45:07
Documents
13
Period of Report
2025-06-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0244374-8k_incannex.htm   iXBRL 8-K 26994
2 PRESS RELEASE OF INCANNEX HEALTHCARE INC., DATED JUNE 3, 2025 ea024437401ex99-1_incannex.htm EX-99.1 19530
  Complete submission text file 0001213900-25-050327.txt   220992

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ixhl-20250603.xsd EX-101.SCH 3023
4 XBRL LABEL FILE ixhl-20250603_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE ixhl-20250603_pre.xml EX-101.PRE 22364
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0244374-8k_incannex_htm.xml XML 3787
Mailing Address 8 CENTURY CIRCUIT STE. 105 NORWEST NSW C3 2153
Business Address 8 CENTURY CIRCUIT STE. 105 NORWEST NSW C3 2153 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 251017176
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)